MicroRNAs as pharmacological targets in diabetes.

MicroRNAs as pharmacological targets in diabetes.
复制标题

DOI:
10.1016/j.phrs.2013.06.005
复制
发表时间:
2013-09
影响因子:
9.3
通讯作者:
Tang, Xiaoqing
Tang, Xiaoqing
中科院分区:
医学1区
文献类型:
--
作者:
Mao, Yiping;Mohan, Ramkumar;Zhang, Shungang;Tang, Xiaoqing

文献摘要

参考文献

被引文献

相似文献

糖尿病的特征在于高水平的血糖,这是由于胰腺中产生胰岛素的β细胞的损失,导致1型糖尿病中的胰岛素缺乏,或者由于胰岛素抵抗增加,导致2型糖尿病中胰岛素敏感性和生产力降低。越来越需要新的选择来治疗糖尿病,特别是2型糖尿病在其早期阶段,由于其在患者中的发展的无效控制。近年来,一类新的非编码小RNA(microRNA,miRNAs)被发现作为基因表达的重要转录和转录后抑制因子,在调控靶信使RNA(mRNAs)中发挥重要作用。miRNAs与糖尿病的发病机制有关,并已成为治疗干预的一个有趣的靶点。本文综述了在各种糖尿病模型中发现的失调的miRNAs,并讨论了miRNAs作为糖尿病治疗靶点的潜力。
Diabetes is characterized by high levels of blood glucose due to either the loss of insulin-producing beta-cells in the pancreas, leading to a deficiency of insulin in type 1 diabetes, or due to increased insulin resistance, leading to reduced insulin sensitivity and productivity in type 2 diabetes. There is an increasing need for new options to treat diabetes, especially type 2 diabetes at its early stages due to the ineffective control of its development in patients. Recently, a novel class of small noncoding RNAs, termed microRNAs (miRNAs), found to play a key role as important transcriptional and posttranscriptional inhibitors of gene expression in fine-tuning the target messenger RNAs (mRNAs). miRNAs are implicated in the pathogenesis of diabetes and have become an intriguing target for therapeutic intervention. This review focuses on the dysregulated miRNAs discovered in various diabetic models and addresses the potential for miRNAs to be therapeutic targets in the treatment of diabetes.
DOI: 10.1371/journal.pbio.0040031
发表时间: 2006-02
期刊: PLoS biology
影响因子: 9.8
作者:
Bordone L;Motta MC;Picard F;Robinson A;Jhala US;Apfeld J;McDonagh T;Lemieux M;McBurney M;Szilvasi A;Easlon EJ;Lin SJ;Guarente L
通讯作者: Guarente L
DOI: 10.1097/shk.0b013e31823f1811
发表时间: 2012-02-01
期刊: SHOCK
影响因子: 3.1
作者:
Andersson, Patrik;Gidlof, Olof;Erlinge, David
通讯作者: Erlinge, David
DOI: 10.2174/157489010793351962
发表时间: 2010-11-01
期刊: Recent patents on cardiovascular drug discovery
影响因子: --
作者:
Bonci, Desiree
通讯作者: Bonci, Desiree
DOI: 10.1016/j.beem.2011.12.002
发表时间: 2012-04-01
影响因子: 7.4
作者:
Barker, Adam;Langenberg, Claudia;Wareham, Nicholas J.
通讯作者: Wareham, Nicholas J.
DOI: 10.1007/s11892-010-0122-6
发表时间: 2010-08-01
影响因子: 4.2
作者:
Cusi, Kenneth
通讯作者: Cusi, Kenneth